Nephron target sites in chronic exposure to lead.
With established urinary markers of kidney integrity the early renal effects of lead have previously been considered to be mainly tubular or tubulointerstitial. In a cross-sectional study on 81 male lead-exposed workers and 45 age-matched controls (median blood lead concentrations 2.03 and 0.34 mumol/l respectively) not only well-established but also new urinary markers of renal integrity preferentially or exclusively located along the different nephron segments were analysed. Markers related to the glomerulus were 6-keto-prostaglandin 1 alpha, thromboxane B2, mainly produced in the glomerulus, and the extracellular matrix protein fibronectin. Markers of the proximal tubule were the brush-border antigens BBA, BB50, and HF5 and the intestinal alkaline phosphatase. Prostaglandin E2 and F2 alpha, preferentially synthesized in the collecting duct and medullary interstitial cells, served as markers of these more distal nephron segments. In contrast to previous studies on the early phase of lead nephrotoxicity, not only tubular but also glomerular involvement could be shown in the study presented here by increases in the median values of 6-keto-prostaglandin 1 alpha and decreases in fibronectin. The proximal tubular markers intestinal alkaline phosphatase and BBA confirmed that this particular segment of the nephron is affected by lead. Effects on the collecting tubule or medullary interstitial cells could also be observed. It is concluded that lead affects both the glomerulus and the tubular apparatus and that combinations of new and established markers could be valuable for a better definition and early detection of lead nephropathy.
Fels
L M
LM
Division of Nephrology, Medical School, Hannover, Germany.
Herbort
C
C
Pergande
M
M
Jung
K
K
Hotter
G
G
Roselló
J
J
Gelpi
E
E
Mutti
A
A
De Broe
M
M
Stolte
H
H
D000328:Adult; D000368:Aged; D015415:Biomarkers; D006801:Humans; D007678:Kidney Glomerulus / Q000187:drug effects; D007685:Kidney Tubules, Collecting / Q000187:drug effects; D007687:Kidney Tubules, Proximal / Q000187:drug effects; D007854:Lead / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009399:Nephrons / Q000187:drug effects*; D016273:Occupational Exposure / Q000009:adverse effects*
D015415:Biomarkers; D007854:Lead